Robert E. Landry
2019
Compensation breakdown
Non-Equity Incentive Plan | $811,395 |
---|---|
Option Awards | $3,526,669 |
Salary | $730,000 |
Stock Awards | $2,840,008 |
Other | $23,470 |
Total | $7,931,542 |
Landry received $3.5M in option awards, accounting for 44% of the total pay in 2019.
Landry also received $811.4K in non-equity incentive plan, $730K in salary, $2.8M in stock awards and $23.5K in other compensation.
Rankings
In 2019, Robert E. Landry's compensation ranked 1,106th out of 13,971 executives tracked by ExecPay. In other words, Landry earned more than 92.1% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 1,106 | 92nd |
Manufacturing | 384 | 93rd |
Chemicals And Allied Products | 114 | 95th |
Drugs | 90 | 95th |
Pharmaceutical Preparations | 68 | 95th |
Landry's colleagues
We found four more compensation records of executives who worked with Robert E. Landry at Regeneron Pharmaceuticals in 2019.
2019
Leonard Schleifer
Regeneron Pharmaceuticals
Chief Executive Officer
2019
George Yancopoulos
Regeneron Pharmaceuticals
Chief Scientific Officer
2019
Andrew Murphy
Regeneron Pharmaceuticals
Executive Vice President, Research
2019
Daniel Van Plew
Regeneron Pharmaceuticals
Executive Vice President and General Manager, Industrial Operations and Product Supply
News
April 21, 2022
April 23, 2021
April 24, 2020
April 26, 2019